COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

24,054 Articles (18,312 medRxiv, 5,742 bioRxiv)

Most recent first Previous |  Page 2021: Articles 20201-20210  | Next

COVID-19: the key role of pulmonary capillary leakage. An observational cohort study
Wu, M. A., Fossali, T., Pandolfi, L., Carsana, L., Ottolina, D., Frangipane, V., Rech, R., Tosoni, A., Agarossi, A., Cogliati, C., Meloni, F., Marchini, B., Nebuloni, M., Catena, E., Colombo, R.
10.1101/2020.05.17.20104877 — Posted: 2020-05-21
Development and Validation of Two In-house, Low-Cost SARS-CoV-2 Detection Assays
Alhamlan, F., Alqahtani, A., Bakheet, D., Bohol, M., Althawadi, S., Mutabagani, M., Almaghrabi, R., Obeid, D.
10.1101/2020.05.18.20105510 — Posted: 2020-05-21
Simulating the progression of the COVID-19 disease in Cameroon using SIR models
NGUEMDJO, U. K., MENO, F., DONGFACK, A., VENTELOU, B.
10.1101/2020.05.18.20105551 — Posted: 2020-05-21
An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2
Ren, X.-d., Tang, Q.-M., Chen, M., Huang, Q., Huang, H.-L., Wang, L., Su, N., Sun, X.-G., Wei, K., Lu, W.-P., Deng, S.-L., Huang, Q.
10.1101/2020.05.18.20105247 — Posted: 2020-05-21
The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19
Li, K., Wu, M., Huang, B., Zhong, A., Li, L., Cai, Y., Wu, L., Zhu, M., Li, J., Wang, Z., Wu, W., Li, W., Bosco, B., Gan, Z., Wang, Z., Qiao, Q., Wu, J., wang, q., Wang, S., Xia, X.
10.1101/2020.05.18.20105155 — Posted: 2020-05-21
Fuzzy Autocatalytic analysis of Covid-19 outbreak in Malaysia
Ahmad, T., Ashaari, A., Awang, S. R., Mamat, S. S., Wan Mohamad, W. M., Ahmad Fuad, A. A., Hassan, N.
10.1101/2020.05.17.20104968 — Posted: 2020-05-21
Modelling to Predict Hospital Bed Requirements for Covid-19 Patients in California
Basu, S.
10.1101/2020.05.17.20104919 — Posted: 2020-05-21
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., Gherardin, N. A., Pymm, P., Dietrich, M. H., Scott, N. E., Tham, W.-H., Godfrey, D. I., Subbarao, K., Davenport, M. P., Kent, S. J., Wheatley, A. K.
10.1101/2020.05.17.20104869 — Posted: 2020-05-21
Impact of Superspreaders on dissemination and mitigation of COVID-19
Sneppen, K., Simonsen, L.
10.1101/2020.05.17.20104745 — Posted: 2020-05-21
Current tobacco smoking and risk from COVID-19: results from a population symptom app in over 2.4 million people
Hopkinson, N. S., Rossi, N., El-Sayed Moustafa, J., Laverty, A. A., Quint, J. K., Freydin, M. B., Visconti, A., Murray, B., Modat, M., Ourselin, S., Small, K., Davies, R., Wolf, J., Spector, T., Steves, C. J., Falchi, M.
10.1101/2020.05.18.20105288 — Posted: 2020-05-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).